Objective: The purpose of the present study was to characterize prescription stimulant non-medical use (NMU) in adolescents between the ages of 13 and 18 years seeking treatment for substance use disorder (SUD) with the Comprehensive Health Assessment Tool for Teens (CHAT™). Method: Adolescents being evaluated for SUD treatment between Q1 2010 and Q3 2017 (n = 20,189) completed the CHAT™. Results: About 4.3% of the sample (N = 867) of adolescents in SUD treatment reported past 30-day prescription stimulant NMU. Compared to those without past 30-day prescription stimulant NMU, more reported a lifetime diagnosis of learning disorder or ADHD, more took medication for emotional, behavioral, or learning disorders, received past-month inpatient treatment, or were currently not enrolled in school. Prescription stimulants were most often taken orally for NMU, however, approximately half reported using alternate routes of administration, the most prominent of which was intranasal use. Conclusion: About 4.3% of adolescents in SUD treatment evaluation reported past 30-day prescription stimulant NMU. Greater percentages of lifetime learning disorder, medication use, past-month inpatient treatment, school unenrollment, and overall substance misuse were associated with prescription stimulant NMU, as were alternate routes of administration. These data reveal an ongoing, persistent level of past-30-day NMU of prescription stimulants among adolescents being evaluated for SUD treatment.
BensonK.FloryK.HumphreysK. L.LeeS. S. (2015). Misuse of stimulant medication among college students: A comprehensive review and meta-analysis. Clinical Child and Family Psychology Review, 18(1), 50–76. https://doi.org/10.1007/s10567-014-0177-z
3.
BurtnerJ.BehlingM.CassidyT.ButlerS. F. (2018). Prevalence of nonmedical use and routes of administration for prescription stimulant medications among adults in a substance abuse treatment population. Journal of Addictive Diseases, 37(1–2), 34–45. https://doi.org/10.1080/10550887.2018.1512825
4.
ButlerS. F.BudmanS. H.GoldmanR. J.NewmanF. L.BeckleyK. E.TrottierD.CacciolaJ. S. (2001). Initial validation of a computer-administered Addiction Severity Index: The ASI-MV. Psychology of Addictive Behaviors, 15(1), 4–12. https://doi.org/10.1037/0893-164x.15.1.4
5.
ButlerS. F.BudmanS. H.LicariA.CassidyT. A.LioyK.DickinsonJ.BrownsteinJ. S.BenneyanJ. C.GreenT. C.KatzN. (2008). National addictions vigilance intervention and prevention program (NAVIPPRO): A real-time, product-specific, public health surveillance system for monitoring prescription drug abuse. Pharmacoepidemiology and Drug Safety, 17(12), 1142–1154. https://doi.org/10.1002/pds.1659
6.
CassidyT. A.McNaughtonE. C.VarugheseS.RussoL.ZuluetaM.ButlerS. F. (2015). Nonmedical use of prescription ADHD stimulant medications among adults in a substance abuse treatment population: Early findings from the NAVIPPRO surveillance system. Journal of Attention Disorders, 19(4), 275–283. https://doi.org/10.1177/1087054713493321
7.
CepedaJ. A.AstemborskiJ.KirkG. D.CelentanoD. D.ThomasD. L.MehtaS. H. (2019). Rising role of prescription drugs as a portal to injection drug use and associated mortality in Baltimore, Maryland. PLoS ONE, 14(3), e0213357. https://doi.org/10.1371/journal.pone.0213357
8.
ChackoA.NewcornJ. H.FeirsenN.UdermanJ. Z. (2010). Improving medication adherence in chronic pediatric health conditions: A focus on ADHD in youth. Current Pharmaceutical Design, 16(22), 2416–2423. https://doi.org/10.2174/138161210791959908
9.
ColaneriN. M.KeimS.AdesmanA. (2017). Physician practices to prevent ADHD stimulant diversion and misuse. Journal of Substance Abuse Treatment, 74, 26–34. https://doi.org/10.1016/j.jsat.2016.12.003
10.
ColaneriN. M.KeimS. A.AdesmanA. (2020). Physician perceptions of ADHD stimulant diversion and misuse. Journal of Attention Disorders, 24(2), 290–300. https://doi.org/10.1177/1087054716649664
11.
CottlerL. B.StrileyC. W.LasopaS. O. (2013). Assessing prescription stimulant use, misuse, and diversion among youth 10–18 years of age. Current Opinions in Psychiatry, 26(5), 511–519.
12.
DeSantisA. D.AnthonyK. E.CohenE. L. (2013). Illegal college ADHD stimulant distributors: Characteristics and potential areas of intervention. Substance Use & Misuse, 48(6), 446–456. https://doi.org/10.3109/10826084.2013.778281
13.
FaraoneS. V.HessJ.WilensT. (2019a). Prevalence and consequences of the nonmedical use of amphetamine among persons calling poison control centers. Journal of Attention Disorders, 23(11), 1219–1228. https://doi.org/10.1177/1087054719843182
14.
FaraoneS. V.RostainA. L.MontanoC. B.MasonO.AntshelK. M.NewcornJ. H. (2019b). Systematic review: Nonmedical use of prescription stimulants: Risk factors, outcomes, and risk reduction strategies. Journal of the American Academy of Child & Adolescent Psychiatry, 59(1), 100–112. https://doi.org/10.1016/j.jaac.2019.06.012
15.
JohnstonL. D.MiechR. A.O’MalleyP. M.BachmanJ. G.SchulenbergJ. E.PatrickM. E. (2019). Monitoring the future national survey results on drug use, 1975–2018: Overview, key findings on adolescent drug use. Institute for Social Research, The University of Michigan.
16.
KatzN.DartR. C.BaileyE.TrudeauJ.OsgoodE.PaillardF. (2011). Tampering with prescription opioids: Nature and extent of the problem, health consequences, and solutions. The American Journal of Drug and Alcohol Abuse, 37(4), 205–217. https://doi.org/10.3109/00952990.2011.569623
17.
KingS. A.CasavantM. J.SpillerH. A.HodgesN. L.ChounthirathT.SmithG. A. (2018). Pediatric ADHD medication exposures reported to US poison control centers. Pediatrics, 141(6), e20173872. https://doi.org/10.1542/peds.2017-3872
18.
KnudsenH. K. (2009). Adolescent-only substance abuse treatment: Availability and adoption of components of quality. Journal of Substance Abuse Treatment, 36(2), 195–204. https://doi.org/10.1016/j.jsat.2008.06.002
19.
LasopaS. O.StrileyC. W.CottlerL. B. (2015). Diversion of prescription stimulant drugs among 10-18-year-olds. Current Opinion in Psychiatry, 28(4), 292–298. https://doi.org/10.1097/YCO.0000000000000172
20.
LeaheyP. A.LaSalviaM. T.RosenthalE. S.KarchmerA. W.RowleyC. F. (2019). High morbidity and mortality among patients with sentinel admission for injection drug use-related infective endocarditis. Open Forum Infectious Diseases, 6(4), ofz089. https://doi.org/10.1093/ofid/ofz089
21.
LordS. E.TrudeauK. J.BlackR. A.LorinL.CooneyE.VillapianoA.ButlerS. F. (2011). CHAT: Development and validation of a computer-delivered, self-report, substance use assessment for adolescents. Substance Use & Misuse, 46(6), 781–794. https://doi.org/10.3109/10826084.2010.538119
22.
McCabeS. E.TeterC. J. (2007). Drug use related problems among nonmedical users of prescription stimulants: A web-based survey of college students from a Midwestern university. Drug and Alcohol Dependence, 91(1), 69–76. https://doi.org/10.1016/j.drugalcdep.2007.05.010
23.
McCabeS. E.TeterC. J.BoydC. J. (2004). The use, misuse and diversion of prescription stimulants among middle and high school students. Substance Use & Misuse, 39(7), 1095–1116. https://doi.org/10.1081/ja-120038031
24.
McCabeS. E.VelizP.WilensT. E.SchulenbergJ. E. (2017). Adolescents’ prescription stimulant use and adult functional outcomes: A national prospective study. Journal of the American Academy of Child & Adolescent Psychiatry, 56(3), 226–233.e224. https://doi.org/10.1016/j.jaac.2016.12.008
25.
McCabeS. E.WestB. T. (2013). Medical and nonmedical use of prescription stimulants: Results from a national multicohort study. Journal of the American Academy of Child & Adolescent Psychiatry, 52(12), 1272–1280. https://doi.org/10.1016/j.jaac.2013.09.005
26.
McCabeS. E.WestB. T.MoralesM.CranfordJ. A.BoydC. J. (2007). Does early onset of non-medical use of prescription drugs predict subsequent prescription drug abuse and dependence? Results from a national study. Addiction, 102(12), 1920–1930. https://doi.org/10.1111/j.1360-0443.2007.02015.x
27.
McCabeS. E.WestB. T.SchepisT. S.TeterC. J. (2015). Simultaneous co-ingestion of prescription stimulants, alcohol and other drugs: A multi-cohort national study of US adolescents. Human Psychopharmacology, 30(1), 42–51. https://doi.org/10.1002/hup.2449
28.
McCabeS. E.WestB. T.TeterC. J.BoydC. J. (2014). Trends in medical use, diversion, and nonmedical use of prescription medications among college students from 2003 to 2013: Connecting the dots. Addictive Behaviors, 39(7), 1176–1182. https://doi.org/10.1016/j.addbeh.2014.03.008
29.
PainoM.AletrarisL.RomanP. M. (2015). Organizational predictors and use of evidence-based practices in adolescent substance abuse treatment. Substance Abuse, 36(4), 462–469. https://doi.org/10.1080/08897077.2014.960959
30.
PeiperN. C.RidenourT. A.HochwaltB.Coyne-BeasleyT. (2016). Overview on prevalence and recent trends in adolescent substance use and abuse. Child and Adolescent Psychiatric Clinics of North America, 25(3), 349–365. https://doi.org/10.1016/j.chc.2016.03.005
31.
PiperB. J.OgdenC. L.SimoyanO. M.ChungD. Y.CaggianoJ. F.NicholsS. D.McCallK. L. (2018). Trends in use of prescription stimulants in the United States and Territories, 2006 to 2016. PLoS ONE, 13(11), e0206100. https://doi.org/10.1371/journal.pone.0206100
32.
PoulinC. (2007). From attention-deficit/hyperactivity disorder to medical stimulant use to the diversion of prescribed stimulants to non-medical stimulant use: Connecting the dots. Addiction, 102(5), 740–751. https://doi.org/10.1111/j.1360-0443.2007.01758.x
SAMSHA. (2019). Key substance use and mental health indicators in the United States: Results from the 2018 National Survey on Drug Use and Health (HHS Publication No. PEP19-5068 NSDUH NSDUH Series H-54). SAMSHA, Center for Behavioral Health Statistics and Quality.
35.
SchepisT. S.WilensT. E.McCabeS. E. (2019). Prescription drug misuse: Sources of controlled medications in adolescents. Journal of the American Academy of Child & Adolescent Psychiatry, 58(7), 670–680.e674. https://doi.org/10.1016/j.jaac.2018.09.438
36.
SecoraA. M.DormitzerC. M.StaffaJ. A.Dal PanG. J. (2014). Measures to quantify the abuse of prescription opioids: A review of data sources and metrics. Pharmacoepidemiology and Drug Safety, 23(12), 1227–1237. https://doi.org/10.1002/pds.3711
37.
TeterC. J.McCabeS. E.LaGrangeK.CranfordJ. A.BoydC. J. (2006). Illicit use of specific prescription stimulants among college students: Prevalence, motives, and routes of administration. Pharmacotherapy, 26(10), 1501–1510. https://doi.org/10.1592/phco.26.10.1501
38.
U.S. Drug Enforcement Administration. (2012). National Forensic Laboratory Information System special report: ADD/ADHD stimulants in NFLIS, 2007–2011. U.S. Drug Enforcement Administration, Office of Diversion Control.
39.
WangY.CottlerL. B.StrileyC. W. (2015). Differentiating patterns of prescription stimulant medical and nonmedical use among youth 10–18 years of age. Drug and Alcohol Dependence, 157, 83–89. https://doi.org/10.1016/j.drugalcdep.2015.10.006
40.
WeyandtL. L.MarracciniM. E.GudmundsdottirB. G.ZavrasB. M.TurcotteK. D.MunroB. A.AmorosoA. J. (2013). Misuse of prescription stimulants among college students: A review of the literature and implications for morphological and cognitive effects on brain functioning. Experimental and Clinical Psychopharmacology, 21(5), 385–407. https://doi.org/10.1037/a0034013
41.
WilensT. E.AdlerL. A.AdamsJ.SgambatiS.RotrosenJ.SawtelleR.UtzingerL.FusilloS. (2008). Misuse and diversion of stimulants prescribed for ADHD: A systematic review of the literature. Journal of the American Academy of Child & Adolescent Psychiatry, 47(1), 21–31. https://doi.org/10.1097/chi.0b013e31815a56f1
42.
WilensT. E.IsenbergB. M.KaminskiT. A.LyonsR. M.QuinteroJ. (2018). Attention-deficit/hyperactivity disorder and transitional aged youth. Current Psychiatry Reports, 20(11), 100. https://doi.org/10.1007/s11920-018-0968-x
43.
ZoselA.BartelsonB. B.BaileyE.LowensteinS.DartR. (2013). Characterization of adolescent prescription drug abuse and misuse using the Researched Abuse Diversion and Addiction-related Surveillance (RADARS®) System. Journal of the American Academy of Child & Adolescent Psychiatry, 52(2), 196–204.e192. https://doi.org/10.1016/j.jaac.2012.11.014
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
